MWF-Chr 6SHR/Rkb |
serum creatinine level |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
blood creatinine amount |
female |
168 days
| 20 |
0.48 |
mg/dl |
0.01 |
0.06 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
68176 |
309 |
Hsd:WI |
serum creatinine level |
1H-pyrazole (10 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
blood creatinine amount |
male |
0 days
| 6 |
1.11 |
mg/dl |
0.25 |
0.62 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
75974 |
1544 |
Hsd:WI |
serum creatinine level |
lycopene (6 mg/kg/d) (for 12 days) then cisplatin (7 mg/kg) |
Erman F, et al., Biol Trace Elem Res. 2014 Feb 16. |
blood creatinine amount |
not specified |
78 days
| 7 |
0.4 |
mg/dl |
0.01 |
0.03 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
76043 |
1546 |
Crl:CD(SD) |
serum creatinine level |
control condition (for 28 days) then vehicle control condition (for 84 days) |
Jia G, et al., Pediatr Nephrol. 2010 Jun;25(6):1139-46. Epub 2010 Mar 13. |
blood creatinine amount |
male |
112 days
| 5 |
0.43 |
mg/dl |
0.03 |
0.07 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
100766 |
2521 |
SD |
serum creatinine level |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then paricalcitol (0.8 mg/kg) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
blood creatinine amount |
female |
0 days
| 10 |
1.5 |
mg/dl |
0.11 |
0.35 |
serum creatinine analysis |
0.0 |
unx |
97 |
days |
|
|
100639 |
2499 |
SHR/NCrlCrlj |
serum creatinine level |
unilateral nephrectomy (for 42 days) then controlled candesartan content drinking water (1 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood creatinine amount |
male |
126 days
| 8 |
0.67 |
mg/dl |
0.04 |
0.11 |
serum creatinine analysis |
0.0 |
unx |
42 |
days |
|
|
101247 |
2583 |
SS.ZUC-Leprfa-/-/Slc |
serum creatinine level |
fasting (for 16 hours) |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
blood creatinine amount |
male |
126 days
| 7 |
1.09 |
mg/dl |
0.19 |
0.5 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
101934 |
2642 |
SD |
serum creatinine level |
control condition |
Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. |
blood creatinine amount |
male |
120 days
| 3 |
0.55 |
mg/dl |
0.01 |
0.01 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
100206 |
2439 |
SS.ZUC-Leprfa+/+/Slc |
serum creatinine level |
everolimus (0.83 mg/kg/d) (for 28 days) |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood creatinine amount |
male |
91 days
| 10 |
0.34 |
mg/dl |
0.01 |
0.03 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
101874 |
2641 |
LOU/M |
serum creatinine level |
control condition |
van Hoesel QG, etal., J Natl Cancer Inst. 1986 Feb;76(2):299-307. |
blood creatinine amount |
female |
84 days
| 43 |
0.43 |
mg/dl |
0.01 |
0.03 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
109291 |
3144 |
SD |
serum creatinine level |
control condition |
Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. |
blood creatinine amount |
male |
60 days
| 3 |
0.53 |
mg/dl |
0.02 |
0.04 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
100204 |
2439 |
MWF/Fub |
serum creatinine level |
control condition |
Schulz A, et al., J Am Soc Nephrol 2003 Dec;14(12):3081-9. |
blood creatinine amount |
male |
126 days
| 8 |
0.58 |
mg/dl |
0.07 |
0.2 |
serum creatinine analysis |
|
|
0 |
|
|
|
13006 |
325 |
MWF-Chr 6SHR/Rkb |
serum creatinine level |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
blood creatinine amount |
not specified |
168 days
| 19 |
0.43 |
mg/dl |
0.02 |
0.08 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
65374 |
117 |
MWF/FubRkb |
serum creatinine level |
control condition |
Schulz A, et al., J Am Soc Nephrol 2002 Nov;13(11):2706-14. |
blood creatinine amount |
not specified |
0 days
| 8 |
0.49 |
mg/dl |
0.0 |
0.01 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
67605 |
769 |
SS-Renem1Mcwi+/+ |
serum creatinine level |
controlled sodium content diet (0.4 %) (for 42 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
blood creatinine amount |
male |
63 days
| 5 |
0.22 |
mg/dl |
0.03 |
0.07 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
98343 |
2038 |
Hsd:WI |
serum creatinine level |
cisplatin (7 mg/kg) |
Erman F, et al., Biol Trace Elem Res. 2014 Feb 16. |
blood creatinine amount |
not specified |
78 days
| 7 |
1.37 |
mg/dl |
0.21 |
0.56 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
76040 |
1546 |
LEW/Rkb |
serum creatinine level |
control condition |
Schulz A, et al., J Am Soc Nephrol 2002 Nov;13(11):2706-14. |
blood creatinine amount |
not specified |
0 days
| 8 |
0.42 |
mg/dl |
0.0 |
0.0 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
67606 |
769 |
SS/NEisSlc |
serum creatinine level |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then vehicle control condition (for 49 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
blood creatinine amount |
male |
126 days
| 8 |
0.47 |
mg/dl |
0.04 |
0.11 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
102326 |
2684 |
SS/NEisSlc |
serum creatinine level |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then tolvaptan (0.05 %) (for 49 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
blood creatinine amount |
male |
126 days
| 8 |
0.35 |
mg/dl |
0.01 |
0.03 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
102327 |
2684 |
SR/NEisSlc |
creatinine clearance |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
glomerular filtration trait |
male |
126 days
| 8 |
3.9 |
ml/min |
0.8 |
2.26 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
102331 |
2684 |
MWF |
serum creatinine level |
lisinopril (80-100 mg/l) |
Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22. |
blood creatinine amount |
male |
280 days
| 10 |
0.77 |
mg/dl |
0.06 |
0.19 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
100245 |
2459 |
SD |
creatinine clearance |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then paricalcitol (0.8 mg/kg) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
glomerular filtration trait |
female |
0 days
| 10 |
0.35 |
ml/min |
0.02 |
0.06 |
serum creatinine analysis |
0.0 |
unx |
97 |
days |
|
|
100644 |
2499 |
PCK-Pkhd1pck/CrljCrl |
serum creatinine level |
control condition (for 28 days) then vehicle control condition (for 84 days) |
Jia G, et al., Pediatr Nephrol. 2010 Jun;25(6):1139-46. Epub 2010 Mar 13. |
blood creatinine amount |
male |
112 days
| 5 |
0.51 |
mg/dl |
0.04 |
0.09 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
100765 |
2521 |
FHH/EurMcwi |
creatinine clearance to total kidney weight ratio |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
glomerular filtration trait |
male |
56 days
| 6 |
1.2 |
ml/min/g |
0.07 |
0.17 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
99489 |
2318 |
SHR/NCrlCrlj |
serum creatinine level |
unilateral nephrectomy (for 42 days) then controlled delapril content drinking water (30 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood creatinine amount |
male |
126 days
| 9 |
0.74 |
mg/dl |
0.04 |
0.12 |
serum creatinine analysis |
0.0 |
unx |
42 |
days |
|
|
101248 |
2583 |
WI |
creatinine clearance to body weight ratio |
controlled in utero environment (for 21 days) and standard diet (50 % of calories) (for 21 days) |
Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10. |
glomerular filtration trait |
male |
102 days
| 6 |
0.48 |
ml/min/100g |
0.08 |
0.18 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
101066 |
2563 |
SS.ZUC-Leprfa+/+/Slc |
creatinine clearance to body weight ratio |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
glomerular filtration trait |
male |
91 days
| 8 |
0.43 |
ml/min/100g |
0.03 |
0.08 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
101877 |
2641 |
SS.ZUC-Leprfa-/-/Slc |
creatinine clearance to total kidney weight ratio |
everolimus (0.83 mg/kg/d) (for 28 days) |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
glomerular filtration trait |
male |
91 days
| 12 |
0.28 |
ml/min/g |
0.04 |
0.14 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
101884 |
2641 |
SS-Renem1Mcwi+/+ |
serum creatinine level |
controlled sodium content diet (0.4 %) (for 42 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
blood creatinine amount |
male |
63 days
| 8 |
0.53 |
mg/dl |
0.02 |
0.06 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
98345 |
2038 |
LOU/M |
serum creatinine level |
doxorubicin (1 mg/kg) (for 49 days) |
van Hoesel QG, etal., J Natl Cancer Inst. 1986 Feb;76(2):299-307. |
blood creatinine amount |
female |
133 days
| 43 |
0.61 |
mg/dl |
0.0 |
0.03 |
serum creatinine analysis |
0.0 |
XCO:0000539 |
49 |
days |
intravenous |
|
109293 |
3144 |
MWF/Ztm |
serum creatinine level |
control condition |
Remuzzi A, etal., Kidney Int. 2006 Apr;69(7):1124-30. doi: 10.1038/sj.ki.5000060. |
blood creatinine amount |
male |
350 days
| 9 |
1.22 |
mg/dl |
0.05 |
0.15 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
109951 |
3158 |
MWF/Fub |
serum creatinine level |
control condition |
Kreutz R, etal., J Hypertens. 2007 Nov;25(11):2308-16. doi: 10.1097/HJH.0b013e3282ef8611. |
blood creatinine amount |
male |
112 days
| 8 |
0.63 |
mg/dl |
0.02 |
0.06 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
109864 |
3156 |
SHR/FubRkb |
serum creatinine level |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
blood creatinine amount |
male |
168 days
| 10 |
0.4 |
mg/dl |
0.01 |
0.04 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
108946 |
3133 |
MWF/FubRkb |
serum creatinine level |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
blood creatinine amount |
female |
168 days
| 10 |
0.47 |
mg/dl |
0.01 |
0.04 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
108951 |
3133 |
MWF-Chr 8SHR/Rkb |
creatinine clearance |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
glomerular filtration trait |
male |
168 days
| 10 |
0.0 |
ml/min |
0.0 |
0.0 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
108954 |
3133 |
MWF/FubRkb |
creatinine clearance |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
glomerular filtration trait |
female |
168 days
| 10 |
0.0 |
ml/min |
0.0 |
0.0 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
108957 |
3133 |
WKY |
serum creatinine level |
control condition |
Macconi D, etal., J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19. |
blood creatinine amount |
male |
350 days
| 4 |
0.34 |
mg/dl |
0.02 |
0.04 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
109547 |
3147 |
WKY |
serum creatinine level |
control condition |
Macconi D, etal., J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19. |
blood creatinine amount |
male |
420 days
| 4 |
0.32 |
mg/dl |
0.04 |
0.07 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
109548 |
3147 |
PCK-Pkhd1pck/CrljCrl |
serum creatinine level |
control condition |
Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. |
blood creatinine amount |
male |
180 days
| 4 |
0.58 |
mg/dl |
0.14 |
0.24 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
100207 |
2439 |
SHR/Fub |
serum creatinine level |
control condition |
Schulz A, et al., J Am Soc Nephrol 2003 Dec;14(12):3081-9. |
blood creatinine amount |
male |
126 days
| 8 |
0.77 |
mg/dl |
0.16 |
0.44 |
serum creatinine analysis |
|
|
0 |
|
|
|
13012 |
325 |
SS-Renem1Mcwi+/+ |
serum creatinine level |
controlled sodium content diet (0.4 %) (for 42 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
blood creatinine amount |
female |
63 days
| 8 |
0.27 |
mg/dl |
0.03 |
0.08 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
98346 |
2038 |
SS-Renem1Mcwi+/+ |
serum creatinine level |
controlled sodium content diet (0.4 %) (for 42 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
blood creatinine amount |
female |
63 days
| 4 |
0.43 |
mg/dl |
0.03 |
0.06 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
98348 |
2038 |
SHR/FubRkb |
serum creatinine level |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
blood creatinine amount |
not specified |
168 days
| 10 |
0.4 |
mg/dl |
0.01 |
0.04 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
65373 |
117 |
MWF/FubRkb |
serum creatinine level |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
blood creatinine amount |
not specified |
168 days
| 18 |
0.42 |
mg/dl |
0.01 |
0.05 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
65375 |
117 |
SD |
creatinine clearance |
left nephrectomy (for 70 days) then puromycin (100 mg/kg) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) then puromycin (80 mg/kg) |
Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. |
glomerular filtration trait |
male |
0 days
| 7 |
0.44 |
ml/min |
0.11 |
0.29 |
serum creatinine analysis |
0.0 |
unx |
70 |
days |
|
|
98994 |
2179 |
FHH-Nr4a1m1Mcwi |
creatinine clearance to total kidney weight ratio |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
glomerular filtration trait |
male |
168 days
| 6 |
0.6 |
ml/min/g |
0.2 |
0.49 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
99494 |
2318 |
WKY |
serum creatinine level |
control condition (for 280 days) |
Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22. |
blood creatinine amount |
male |
280 days
| 9 |
0.53 |
mg/dl |
0.03 |
0.1 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
100246 |
2459 |
MWF |
serum creatinine level |
lisinopril (80-100 mg/l) (for 140 days) |
Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22. |
blood creatinine amount |
male |
420 days
| 10 |
0.91 |
mg/dl |
0.02 |
0.06 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
100250 |
2459 |
SD |
serum creatinine level |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then vehicle control condition (100 ul) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
blood creatinine amount |
female |
0 days
| 13 |
1.65 |
mg/dl |
0.14 |
0.5 |
serum creatinine analysis |
0.0 |
unx |
97 |
days |
|
|
100637 |
2499 |
SD |
serum creatinine level |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then paricalcitol (0.8 mg/kg) (for 90 days) and enalapril (25 mg/l) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
blood creatinine amount |
female |
0 days
| 12 |
0.93 |
mg/dl |
0.05 |
0.17 |
serum creatinine analysis |
0.0 |
unx |
97 |
days |
|
|
100640 |
2499 |
SD |
creatinine clearance |
control condition |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
glomerular filtration trait |
female |
0 days
| 8 |
0.96 |
ml/min |
0.07 |
0.2 |
serum creatinine analysis |
0.0 |
- |
0 |
days |
|
|
100641 |
2499 |
SHR/NCrlCrlj |
serum creatinine level |
unilateral nephrectomy (for 42 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood creatinine amount |
male |
126 days
| 5 |
0.95 |
mg/dl |
0.08 |
0.18 |
serum creatinine analysis |
0.0 |
unx |
42 |
days |
|
|
101246 |
2583 |
SHR/NCrlCrlj |
serum creatinine level |
unilateral nephrectomy (for 42 days) then controlled hydralazine content drinking water (15 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
blood creatinine amount |
male |
126 days
| 5 |
0.92 |
mg/dl |
0.06 |
0.13 |
serum creatinine analysis |
0.0 |
unx |
42 |
days |
|
|
101249 |
2583 |
SS-Nppbem2Mcwi+/+ |
serum creatinine level |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
blood creatinine amount |
male |
252 days
| 6 |
0.3 |
mg/dl |
0.1 |
0.24 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
99750 |
2319 |
WI |
creatinine clearance to body weight ratio |
controlled in utero environment (for 21 days) and standard diet (100 % of calories) (for 21 days) |
Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10. |
glomerular filtration trait |
male |
102 days
| 6 |
0.54 |
ml/min/100g |
0.06 |
0.13 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
101065 |
2563 |
MWF/Ztm |
serum creatinine level |
control condition |
Macconi D, etal., J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19. |
blood creatinine amount |
male |
350 days
| 7 |
0.77 |
mg/dl |
0.11 |
0.3 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
109541 |
3147 |
MWF/Ztm |
serum creatinine level |
controlled lisinopril content drinking water (80 mg/l) (for 1 days) |
Macconi D, etal., J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19. |
blood creatinine amount |
male |
280 days
| 8 |
0.57 |
mg/dl |
0.04 |
0.12 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
109543 |
3147 |
MWF/Ztm |
serum creatinine level |
controlled lisinopril content drinking water (80 mg/l) (for 140 days) |
Macconi D, etal., J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19. |
blood creatinine amount |
male |
420 days
| 8 |
0.61 |
mg/dl |
0.03 |
0.08 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
109545 |
3147 |
MWF/FubRkb |
serum creatinine level |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
blood creatinine amount |
female |
168 days
| 18 |
0.47 |
mg/dl |
0.0 |
0.02 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
68177 |
309 |
SS.ZUC-Leprfa-/-/Slc |
serum creatinine level |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood creatinine amount |
male |
91 days
| 7 |
0.34 |
mg/dl |
0.04 |
0.11 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
101875 |
2641 |
SS.ZUC-Leprfa-/-/Slc |
creatinine clearance to total kidney weight ratio |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
glomerular filtration trait |
male |
91 days
| 7 |
0.4 |
ml/min/g |
0.03 |
0.08 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
101883 |
2641 |
FHH-Nr4a1m1Mcwi |
creatinine clearance to total kidney weight ratio |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
glomerular filtration trait |
male |
56 days
| 6 |
1.0 |
ml/min/g |
0.12 |
0.29 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
99490 |
2318 |
FHH/EurMcwi |
creatinine clearance to total kidney weight ratio |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
glomerular filtration trait |
male |
168 days
| 6 |
1.2 |
ml/min/g |
0.2 |
0.49 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
99493 |
2318 |
SR/NEisSlc |
serum creatinine level |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
blood creatinine amount |
male |
126 days
| 8 |
0.22 |
mg/dl |
0.01 |
0.03 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
102325 |
2684 |
MWF |
serum creatinine level |
control condition (for 280 days) |
Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22. |
blood creatinine amount |
male |
280 days
| 10 |
0.76 |
mg/dl |
0.06 |
0.2 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
100244 |
2459 |
MWF |
serum creatinine level |
control condition (for 350 days) |
Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22. |
blood creatinine amount |
male |
350 days
| 10 |
0.97 |
mg/dl |
0.09 |
0.27 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
100247 |
2459 |
MWF |
serum creatinine level |
control condition (for 420 days) |
Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22. |
blood creatinine amount |
male |
402 days-420 days |
10 |
1.77 |
mg/dl |
0.24 |
0.77 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
Ages originally entered as low bound 420 days and high bound 402 days. |
100249 |
2459 |
SD |
creatinine clearance |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then vehicle control condition (100 ul) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
glomerular filtration trait |
female |
0 days
| 13 |
0.3 |
ml/min |
0.03 |
0.11 |
serum creatinine analysis |
0.0 |
unx |
97 |
days |
|
|
100642 |
2499 |
SD |
creatinine clearance |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then paricalcitol (0.8 mg/kg) (for 90 days) and enalapril (25 mg/l) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
glomerular filtration trait |
female |
0 days
| 12 |
0.58 |
ml/min |
0.05 |
0.17 |
serum creatinine analysis |
0.0 |
unx |
97 |
days |
|
|
100645 |
2499 |
SS-Nppbem2Mcwi-/- |
serum creatinine level |
control condition (for 252 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
blood creatinine amount |
male |
252 days
| 6 |
0.4 |
mg/dl |
0.1 |
0.24 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
99751 |
2319 |
SD |
creatinine clearance |
left nephrectomy (for 70 days) |
Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. |
glomerular filtration trait |
male |
0 days
| 5 |
1.4 |
ml/min |
0.2 |
0.45 |
serum creatinine analysis |
0.0 |
unx |
70 |
days |
|
|
103797 |
2179 |
SS.ZUC-Leprfa+/+/Slc |
serum creatinine level |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood creatinine amount |
male |
91 days
| 8 |
0.35 |
mg/dl |
0.01 |
0.03 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
101873 |
2641 |
SS.ZUC-Leprfa+/+/Slc |
creatinine clearance to total kidney weight ratio |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
glomerular filtration trait |
male |
91 days
| 8 |
0.48 |
ml/min/g |
0.02 |
0.06 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
101881 |
2641 |
SS.ZUC-Leprfa+/+/Slc |
serum creatinine level |
fasting (for 16 hours) |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
blood creatinine amount |
male |
126 days
| 6 |
0.32 |
mg/dl |
0.03 |
0.07 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
101933 |
2642 |
SD |
serum creatinine level |
control condition |
Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. |
blood creatinine amount |
male |
180 days
| 5 |
0.55 |
mg/dl |
0.06 |
0.1 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
100208 |
2439 |
Crl:WI |
serum creatinine level |
control condition |
Kreutz R, etal., J Hypertens. 2007 Nov;25(11):2308-16. doi: 10.1097/HJH.0b013e3282ef8611. |
blood creatinine amount |
male |
112 days
| 8 |
0.58 |
mg/dl |
0.03 |
0.08 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
109863 |
3156 |
WKY |
serum creatinine level |
control condition |
Macconi D, etal., J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19. |
blood creatinine amount |
male |
280 days
| 4 |
0.33 |
mg/dl |
0.03 |
0.06 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
109546 |
3147 |
MWF-Chr 8SHR/Rkb |
serum creatinine level |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
blood creatinine amount |
female |
168 days
| 10 |
0.48 |
mg/dl |
0.01 |
0.04 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
108949 |
3133 |
SHR/FubRkb |
creatinine clearance |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
glomerular filtration trait |
female |
168 days
| 10 |
0.0 |
ml/min |
0.0 |
0.0 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
108953 |
3133 |
MWF-Chr 8SHR/Rkb |
creatinine clearance |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
glomerular filtration trait |
female |
168 days
| 10 |
0.0 |
ml/min |
0.0 |
0.0 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
108955 |
3133 |
MWF/FubRkb |
creatinine clearance |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
glomerular filtration trait |
male |
168 days
| 10 |
0.0 |
ml/min |
0.0 |
0.0 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
108956 |
3133 |
Hsd:WI |
serum creatinine level |
silymarin (50 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
blood creatinine amount |
male |
0 days
| 6 |
0.85 |
mg/dl |
0.03 |
0.08 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
75975 |
1544 |
SD |
serum creatinine level |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then enalapril (25 mg/l) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
blood creatinine amount |
female |
0 days
| 12 |
0.93 |
mg/dl |
0.02 |
0.07 |
serum creatinine analysis |
0.0 |
unx |
97 |
days |
|
|
100638 |
2499 |
Hsd:WI |
serum creatinine level |
control condition |
Erman F, et al., Biol Trace Elem Res. 2014 Feb 16. |
blood creatinine amount |
not specified |
78 days
| 7 |
0.29 |
mg/dl |
0.01 |
0.03 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
76038 |
1546 |
SHR/FubRkb |
serum creatinine level |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
blood creatinine amount |
female |
168 days
| 10 |
0.4 |
mg/dl |
0.02 |
0.06 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
68175 |
309 |
Hsd:WI |
serum creatinine level |
vehicle control condition (for 10 days) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
blood creatinine amount |
male |
0 days
| 6 |
0.54 |
mg/dl |
0.01 |
0.03 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
75972 |
1544 |
Hsd:WI |
serum creatinine level |
lycopene (6 mg/kg/d) (for 12 days) |
Erman F, et al., Biol Trace Elem Res. 2014 Feb 16. |
blood creatinine amount |
not specified |
78 days
| 7 |
0.33 |
mg/dl |
0.02 |
0.05 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
76039 |
1546 |
SS/NEisSlc |
creatinine clearance |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then vehicle control condition (for 49 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
glomerular filtration trait |
male |
126 days
| 8 |
1.9 |
ml/min |
0.5 |
1.41 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
102332 |
2684 |
SS/NEisSlc |
creatinine clearance |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then tolvaptan (0.05 %) (for 49 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
glomerular filtration trait |
male |
126 days
| 8 |
3.6 |
ml/min |
0.7 |
1.98 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
102333 |
2684 |
FHH/EurMcwi |
creatinine clearance to total kidney weight ratio |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
glomerular filtration trait |
male |
112 days
| 6 |
0.9 |
ml/min/g |
0.06 |
0.15 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
99491 |
2318 |
FHH-Nr4a1m1Mcwi |
creatinine clearance to total kidney weight ratio |
control condition |
Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. |
glomerular filtration trait |
male |
112 days
| 6 |
0.7 |
ml/min/g |
0.06 |
0.15 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
99492 |
2318 |
MWF |
serum creatinine level |
lisinopril (80-100 mg/l) (for 70 days) |
Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22. |
blood creatinine amount |
male |
350 days
| 10 |
0.86 |
mg/dl |
0.03 |
0.11 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
100248 |
2459 |
SD |
creatinine clearance |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then enalapril (25 mg/l) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
glomerular filtration trait |
female |
0 days
| 12 |
0.56 |
ml/min |
0.03 |
0.1 |
serum creatinine analysis |
0.0 |
unx |
97 |
days |
|
|
100643 |
2499 |
PCK-Pkhd1pck/CrljCrl |
serum creatinine level |
control condition |
Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. |
blood creatinine amount |
male |
120 days
| 3 |
0.57 |
mg/dl |
0.03 |
0.06 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
100205 |
2439 |
SS.ZUC-Leprfa-/-/Slc |
serum creatinine level |
everolimus (0.83 mg/kg/d) (for 28 days) |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood creatinine amount |
male |
91 days
| 12 |
0.37 |
mg/dl |
0.03 |
0.1 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
101876 |
2641 |
SS.ZUC-Leprfa-/-/Slc |
creatinine clearance to body weight ratio |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
glomerular filtration trait |
male |
91 days
| 7 |
0.28 |
ml/min/100g |
0.03 |
0.08 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
101879 |
2641 |
SS.ZUC-Leprfa+/+/Slc |
creatinine clearance to total kidney weight ratio |
everolimus (0.83 mg/kg/d) (for 28 days) |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
glomerular filtration trait |
male |
91 days
| 10 |
0.47 |
ml/min/g |
0.05 |
0.16 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
101882 |
2641 |
SS-Renem1Mcwi+/- |
serum creatinine level |
controlled sodium content diet (0.4 %) (for 42 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
blood creatinine amount |
male |
63 days
| 9 |
0.26 |
mg/dl |
0.02 |
0.06 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
98344 |
2038 |
SS-Renem1Mcwi+/- |
serum creatinine level |
controlled sodium content diet (0.4 %) (for 42 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
blood creatinine amount |
female |
63 days
| 9 |
0.26 |
mg/dl |
0.02 |
0.06 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
98347 |
2038 |
LOU/M |
serum creatinine level |
doxorubicin (1 mg/kg) (for 35 days) |
van Hoesel QG, etal., J Natl Cancer Inst. 1986 Feb;76(2):299-307. |
blood creatinine amount |
female |
119 days
| 43 |
0.57 |
mg/dl |
0.0 |
0.02 |
serum creatinine analysis |
0.0 |
XCO:0000539 |
35 |
days |
|
|
109292 |
3144 |
MWF/Ztm |
serum creatinine level |
control condition |
Remuzzi A, etal., Kidney Int. 2006 Apr;69(7):1124-30. doi: 10.1038/sj.ki.5000060. |
blood creatinine amount |
male |
420 days
| 7 |
1.92 |
mg/dl |
0.29 |
0.77 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
109952 |
3158 |
SHR/FubRkb |
serum creatinine level |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
blood creatinine amount |
female |
168 days
| 10 |
0.4 |
mg/dl |
0.02 |
0.06 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
108947 |
3133 |
MWF-Chr 8SHR/Rkb |
serum creatinine level |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
blood creatinine amount |
male |
168 days
| 10 |
0.44 |
mg/dl |
0.01 |
0.05 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
108948 |
3133 |
MWF/FubRkb |
serum creatinine level |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
blood creatinine amount |
male |
168 days
| 10 |
0.42 |
mg/dl |
0.01 |
0.04 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
108950 |
3133 |
SHR/FubRkb |
creatinine clearance |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
glomerular filtration trait |
male |
168 days
| 10 |
0.0 |
ml/min |
0.0 |
0.0 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
108952 |
3133 |
MWF/Ztm |
serum creatinine level |
control condition |
Macconi D, etal., J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19. |
blood creatinine amount |
male |
280 days
| 7 |
0.57 |
mg/dl |
0.05 |
0.12 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
109540 |
3147 |
MWF/Ztm |
serum creatinine level |
control condition |
Macconi D, etal., J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19. |
blood creatinine amount |
male |
420 days
| 7 |
1.78 |
mg/dl |
0.52 |
1.38 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
109542 |
3147 |
MWF/Ztm |
serum creatinine level |
controlled lisinopril content drinking water (80 mg/l) (for 70 days) |
Macconi D, etal., J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19. |
blood creatinine amount |
male |
350 days
| 8 |
0.66 |
mg/dl |
0.05 |
0.14 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
109544 |
3147 |
SS.ZUC-Leprfa+/+/Slc |
creatinine clearance to body weight ratio |
everolimus (0.83 mg/kg/d) (for 28 days) |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
glomerular filtration trait |
male |
91 days
| 10 |
0.39 |
ml/min/100g |
0.04 |
0.13 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
101878 |
2641 |
SS.ZUC-Leprfa-/-/Slc |
creatinine clearance to body weight ratio |
everolimus (0.83 mg/kg/d) (for 28 days) |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
glomerular filtration trait |
male |
91 days
| 12 |
0.17 |
ml/min/100g |
0.02 |
0.07 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
101880 |
2641 |
SD |
serum creatinine level |
control condition |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
blood creatinine amount |
female |
0 days
| 8 |
0.58 |
mg/dl |
0.03 |
0.08 |
serum creatinine analysis |
0.0 |
|
0 |
days |
|
|
100636 |
2499 |
Hsd:WI |
serum creatinine level |
vehicle control condition (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
blood creatinine amount |
male |
0 days
| 6 |
1.69 |
mg/dl |
0.06 |
0.14 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
75973 |
1544 |
PCK-Pkhd1pck/CrljCrl |
serum creatinine level |
control condition |
Goto M, et al., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. |
blood creatinine amount |
male |
60 days
| 3 |
0.45 |
mg/dl |
0.05 |
0.09 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
|
100203 |
2439 |